HK1212219A1 - 177-lu labeled peptide for site-specific upar-targeting upar 177-lu - Google Patents

177-lu labeled peptide for site-specific upar-targeting upar 177-lu

Info

Publication number
HK1212219A1
HK1212219A1 HK16100118.9A HK16100118A HK1212219A1 HK 1212219 A1 HK1212219 A1 HK 1212219A1 HK 16100118 A HK16100118 A HK 16100118A HK 1212219 A1 HK1212219 A1 HK 1212219A1
Authority
HK
Hong Kong
Prior art keywords
upar
site
targeting
specific
labeled peptide
Prior art date
Application number
HK16100118.9A
Other languages
English (en)
Chinese (zh)
Inventor
．謝爾
．珀森
．卜勞格
Original Assignee
Rigshospitalet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigshospitalet filed Critical Rigshospitalet
Publication of HK1212219A1 publication Critical patent/HK1212219A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK16100118.9A 2012-05-08 2016-01-07 177-lu labeled peptide for site-specific upar-targeting upar 177-lu HK1212219A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201200321 2012-05-08
PCT/DK2013/050126 WO2013167130A1 (en) 2012-05-08 2013-05-03 177-Lu LABELED PEPTIDE FOR SITE-SPECIFIC uPAR-TARGETING

Publications (1)

Publication Number Publication Date
HK1212219A1 true HK1212219A1 (en) 2016-06-10

Family

ID=49550163

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16100118.9A HK1212219A1 (en) 2012-05-08 2016-01-07 177-lu labeled peptide for site-specific upar-targeting upar 177-lu

Country Status (7)

Country Link
US (2) US10994032B2 (xx)
EP (1) EP2846826B1 (xx)
JP (2) JP2015532636A (xx)
CN (1) CN104768573B (xx)
CA (1) CA2905172C (xx)
HK (1) HK1212219A1 (xx)
WO (1) WO2013167130A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10994032B2 (en) * 2012-05-08 2021-05-04 Trt Innovations Aps 177-Lu labeled peptide for site-specific uPAR-targeting
WO2014086364A1 (en) * 2012-12-03 2014-06-12 Rigshospitalet Positron emitting radionuclide labeled peptides for human upar pet imaging
CA2961095C (en) 2014-09-17 2021-02-09 Rigshospitalet Upar targeting peptide for use in perioperative optical imaging of invasive cancer
AU2017260260B2 (en) 2016-05-02 2023-09-14 University Of Pittsburgh -Of The Commonwealth System Of Higher Education Dimerization strategies and compounds for molecular imaging and/or radioimmunotherapy
RU2757768C2 (ru) * 2016-08-19 2021-10-21 ФУДЖИФИЛМ Тояма Кемикал Ко., Лтд. Композиция, содержащая буфер
WO2018091058A1 (en) * 2016-11-17 2018-05-24 Rigshospitalet 177-lu labeled active site inhibited factor vii
TW202005667A (zh) * 2018-04-05 2020-02-01 美商塔維達治療公司 Ｈｓｐ９０－靶向共軛體及其調合物
US10596278B2 (en) 2018-07-25 2020-03-24 Advanced Accelerator Applications (Italy) S.R.L. Stable, concentrated radionuclide complex solutions
US10596276B2 (en) 2018-07-25 2020-03-24 Advanced Accelerator Applications (Italy) S.R.L. Stable, concentrated radionuclide complex solutions
US20240009331A1 (en) 2020-12-01 2024-01-11 Curasight A/S Urokinase plasminogen activator receptor targeted radiolabeled peptide conjugates
WO2023173074A2 (en) * 2022-03-10 2023-09-14 The Research Foundation For The State University Of New York Immunostimulant-cytotoxic conjugate composition and methods for cancer treatment
CN114874308B (zh) * 2022-05-26 2023-02-17 苏州大学 一种核素标记的抑制肽及其制备方法和应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444690A (en) 1982-02-25 1984-04-24 University Patents, Inc. Technetium chelates
US4479930A (en) 1982-07-26 1984-10-30 Trustees Of The University Of Massachusetts Amines coupled wth dicyclic dianhydrides capable of being radiolabeled product
US5120526A (en) 1985-01-14 1992-06-09 Neorx Corporation Method of producing metal radionuclide labeled proteins for diagnosis and therapy
US4861869A (en) 1986-05-29 1989-08-29 Mallinckrodt, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
US4965392A (en) 1987-03-26 1990-10-23 Neorx Corporation Chelating compounds for metal-radionuclide labeled proteins
US5175257A (en) 1989-12-29 1992-12-29 Neorx Corporation Radiolabeled proteins for diagnostic or therapeutic use
US5310536A (en) 1992-02-06 1994-05-10 Mallinckrodt Medical, Inc. Ligands for improving metal chelate formation kinetics
US5830431A (en) * 1995-06-07 1998-11-03 Mallinckrodt Medical, Inc. Radiolabeled peptide compositions for site-specific targeting
US5942492A (en) 1996-11-12 1999-08-24 Angstrom Pharmaceuticals, Inc. Cyclic peptides that bind to urokinase-type plasminogen activator receptor
US6277818B1 (en) 1998-10-29 2001-08-21 Angstrom Pharmaceuticals, Inc. Cyclic peptide ligands that target urokinase plasminogen activator receptor
AR020101A1 (es) 1998-07-01 2002-04-10 Cancerforskingsfonden Af 1989 Un antagonista peptido del receptor de uroquinasa humana, composicion farmaceutica que lo contiene, su uso para la manufactura de un medicamento y metodopara seleccionar un antagonista peptido adecuado.
WO2001025410A2 (en) 1999-10-01 2001-04-12 Angstrom Pharmaceuticals, Inc. DIAGNOSTIC PROBES AND THERAPEUTICS TARGETING uPA AND uPAR
US8568689B1 (en) * 2004-09-29 2013-10-29 Ge Healthcare As uPAR-targeting contrast agents
WO2007044892A2 (en) * 2005-10-10 2007-04-19 American Diagnostica, Inc. Upar-binding molecule-drug conjugates and uses thereof
WO2007134274A2 (en) 2006-05-12 2007-11-22 Attenuon, Llc Antibodies to urokinase- type plasminogen activator receptor(upar)bind cancer stem cells: use in diagnosis and therapy
EP2750717B1 (en) * 2011-08-31 2019-03-27 Somscan ApS Pet tracer for imaging of neuroendocrine tumors
US10994032B2 (en) * 2012-05-08 2021-05-04 Trt Innovations Aps 177-Lu labeled peptide for site-specific uPAR-targeting
WO2014086364A1 (en) * 2012-12-03 2014-06-12 Rigshospitalet Positron emitting radionuclide labeled peptides for human upar pet imaging
CA2961095C (en) * 2014-09-17 2021-02-09 Rigshospitalet Upar targeting peptide for use in perioperative optical imaging of invasive cancer

Also Published As

Publication number Publication date
CN104768573A (zh) 2015-07-08
WO2013167130A1 (en) 2013-11-14
JP2015532636A (ja) 2015-11-12
JP6814234B2 (ja) 2021-01-13
JP2019077712A (ja) 2019-05-23
EP2846826A1 (en) 2015-03-18
US10994032B2 (en) 2021-05-04
CN104768573B (zh) 2017-08-29
CA2905172A1 (en) 2013-11-14
EP2846826A4 (en) 2015-12-23
EP2846826B1 (en) 2018-07-25
US20150132219A1 (en) 2015-05-14
CA2905172C (en) 2021-07-20
US20210236666A1 (en) 2021-08-05

Similar Documents

Publication Publication Date Title
HK1212219A1 (en) 177-lu labeled peptide for site-specific upar-targeting upar 177-lu
IL290884A (en) Particles are attached to the peptide
EP2922877A4 (en) IMPROVED PEPTIDATE MEDICINES
PL3415525T3 (pl) Peptyd amfipatyczny
EP2857033A4 (en) SKIN-PUNKING PEPTIDE
EP2709645A4 (en) ENHANCED PEPTIDE PHARMACEUTICAL AGENTS
IL239285A0 (en) Yogurts with high protein
EP2812347A4 (en) AUTOPHAGIA-INDUCING PEPTIDE
GB201418188D0 (en) Peptide arrays
GB201111183D0 (en) Peptide
GB201115910D0 (en) Peptides
HK1214576A1 (zh) 改進的瓶子
HK1209138A1 (en) Peptides
HK1203836A1 (en) Bifunctional peptide
GB201218278D0 (en) Translocating peptide
GB201200555D0 (en) Peptide
GB201204868D0 (en) Peptides
GB201223114D0 (en) Novel peptide
EP2891663A4 (en) PEPTIDE DERIVED FROM PSF1
EP2714717A4 (en) PHOENIXINPEPTIDE
GB201213672D0 (en) Protein
GB201221414D0 (en) Trans-locating peptide
GB201220328D0 (en) Peptides
GB201211740D0 (en) Peptides
GB201207895D0 (en) Peptides